Expanding Product Portfolio Basepaws has recently launched breed and health DNA tests for both cats and dogs, indicating a strong growth focus in consumer pet genetic testing. This expansion provides opportunities to cross-sell connected health products, personalized pet care solutions, and complementary veterinary services.

Acquisition Leverage Since being acquired by Zoetis, a major player in animal health, Basepaws benefits from access to an extensive distribution network and veterinary partnerships. Business development opportunities exist in joint marketing, new product integration, and leveraging Zoetis’s global reach to increase market penetration.

Veterinary Collaboration Basepaws has developed genetic and microbiome screening tools for veterinary teams, presenting avenues to offer clinics advanced diagnostic services and training packages, thereby expanding revenue streams within veterinary practices.

Market Growth Potential The pet genetic testing market is growing rapidly as pet owners seek proactive health management. Opportunities exist in expanding direct-to-consumer channels, partnering with pet retailers, and developing educational campaigns to increase product adoption among pet owners.

Funding and Revenue Opportunity With annual revenues between $10M and $25M and recent product launches, there is potential to target investments towards marketing, product development, and sales expansion initiatives aimed at scaling customer reach and deepening market share in pet health diagnostics.